22nd International Cyclodextrin Symposium

Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.

The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.

The symposium will cover diverse topics including:
# Cyclodextrin chemistry and characterization
# Novel drug delivery systems
# AI and machine learning in pharmaceutical formulation
# Nanotechnology applications
# Industrial perspectives and commercialization
# Regulatory aspects and quality control
# Clinical applications and case studies

When Cyclodextrin’s Two Homes Met in Kyoto

Last week, Kyoto hosted the 12th Asian Cyclodextrin Conference, bringing together researchers, collaborators, and long-time friends from around the world — including several members of Bicyclos HEurope.

For us at CarboHyde, the event felt like a reunion between the two main “homes” of cyclodextrin science.
Japan has long been a cradle of CD innovation, while Hungary has become another strong home driving cyclodextrins toward new applications and industries. Seeing these two hubs reconnect in Kyoto was inspiring.

Our CSO, Milo Malanga, PhD, was also present — the smiling, chatty Italian in jeans who never misses the chance to ask a sharp question after each lecture. His presence helped spark new conversations and strengthen ongoing collaborations.

The conference offered what makes this community so special: solid science, meaningful dialogue, and friendships that push the field forward.

We return from Kyoto with renewed motivation — ready to turn last week’s ideas into future cyclodextrin innovations.

Connecting biotechnology, agriculture, and pharmaceuticals

We at CarboHyde are proud to see our collaboration with Allbiom – Inteligência em Bioprocessos represented at the CIFARP – International Congress of Pharmaceutical Sciences!

The joint research presented by Lilian Pontes and Amanda Brandão, under the leadership of Dr. Ana Carolina Ré, beautifully demonstrates how cyclodextrins can serve as molecular bridges between agro- and pharma-biotechnology — enabling smarter delivery systems, modulation of microbial processes, and new bioproduction strategies.

This collaboration reflects CarboHyde’s mission to expand the application horizon of cyclodextrins beyond traditional boundaries — harnessing their supramolecular chemistry to open new routes in sustainable innovation.

A big thank you to our partners at Allbiom for their scientific excellence and inspiring teamwork. We’re excited to see where this synergy will lead next!

Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology

While part of the team last week was at EuroCD, Tamas Kiss, PhD was also busy.

We had the privilege to present interesting applications of cyclodextrins in the Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology, organized by the Hungarian Chemical Society.

The lecture presented several fascinating cyclodextrin applications, such as:

1. Cyclarity Therapeutics’ solution for reversing arteriosclerosis with a cyclodextrin dimer (they are in Clinical Phase 1)

2. Oculis’ formulation that contains gamma-cyclodextrin-dexamethasone suspension, which could be an alternative to the intravitreal injection (Clinical Phase 3 completed)

3. Fraunhofer Institute for Building Physics IBP’s gel, which binds the toxic vapour (e.g., lindane) that is released from wood preservatives widespread in Germany

Hidden cyclodextrin innovations

Last week at the EuroCD-25, I talked about how the innovation landscape is changing in the cyclodextrin field.

What was dominated by pharma 20-30-40 years ago is getting taken over by non-pharma these days.

New derivatives (like polymers or conjugates) and innovative drug delivery solutions (like MOFs) emerge and get commercialized in cosmetic, environmental, household and nutraceutical uses.

My talk was not only describing the case studies but also analyzing what was the key to their success, what enabled them to be successful in the market.

In your opinion – what is the key for successful innovation?

Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology in 2025

While part of the team last week was at EuroCD, Tamas Kiss, PhD was also busy.

We had the privilege to present interesting applications of cyclodextrins in the Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology, organized by the Hungarian Chemical Society.

The lecture presented several fascinating cyclodextrin applications, such as:

1. Cyclarity Therapeutics’ solution for reversing arteriosclerosis with a cyclodextrin dimer (they are in Clinical Phase 1)

2. Oculis’ formulation that contains gamma-cyclodextrin-dexamethasone suspension, which could be an alternative to the intravitreal injection (Clinical Phase 3 completed)

3. Fraunhofer Institute for Building Physics IBP’s gel, which binds the toxic vapour (e.g., lindane) that is released from wood preservatives widespread in Germany

David Thompson favorite moments at the EuroCD 2025 – Day3

1. David Thompson sharing innovative using of cationic cyclodextrins for RNA delivery

2. Safety of CDs in deep eutectic solvents François-Xavier Legrand

3. The release of Crysmeb as a novel pharma excipient by Damien TRUFFIN, PhD, ERT and Julien Parcq

4. How nanosponges can help in climaze change, the Dewy story by Adrián Matencio Durán

5. Balázs Attila Kondoros from CarboHyde showing how the industry is using cyclodextrins

6. The poster sessions, with 55 amazing works

7. The flash of Claudia Mautone who did part of her work in our labs.

My highlights at the 2nd Day of EuroCD2025

1. The plenary of Andreas Bernkop-Schnürch on the applications of thiolated cyclodextrins, especially the mucoadhesive use (chaired by Caitriona from.GENEGUT)

2. The collaboration of Roquette and InSiliBio on insilico modelling presented by Vincent Dumouilla

3. Anita Kiss on RotaChrom Technologies‘ cyclodextrin applications

4-5. Milo’s collaborative projects with Cristina Parisi on light-responsive CDs and one with Mary McNamara (Bicyclos HEurope) on targeted delivery

6. Our former secondee Fahad Khan Tareen on intranasal therapeutic delivery

CarboHyde Poster Prize


To be awarded at the 8th European Cyclodextrin Conference

CarboHyde is pleased to sponsor a Poster Prize recognizing the industrially most relevant research presented at the conference.

The award will be granted to a single poster presenter whose work demonstrates outstanding potential for industrial application, as selected by the attending members of CarboHyde.

Prize:
• Award certificate (diploma)
• Fully funded two-week research scholarship at CarboHyde in Budapest, including hands-on laboratory training and mentorship.

The scholarship is intended to support the continuation of the awardee’s research and to foster collaborative development with CarboHyde, with a view to translating academic findings into industrial solutions.

We look forward to engaging with talented researchers and supporting innovation in cyclodextrin science.

EuroCD 2025 CarboHyde